The role of whole blood viscosity in premature coronary artery disease in women

Atherosclerosis

Volumn 165, Issue 2, 2002, Pages 367-373

  De Backer, Tine L M ^a   De Buyzere, Marc ^b   Segers, Patrick ^c   Carlier, Stéphane ^a   De Sutter, Johan ^b   Van de Wiele, Christof ^c   De Backer, Guy ^b  

^a OLV HOSPITAL   (Belgium)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c GHENT UNIVERSITY   (Belgium)

Author keywords

Blood viscosity; Classical risk factors; Premature coronary artery disease; Women

Indexed keywords

CHOLESTEROL; CREATININE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; URIC ACID;

ADULT; ANGINA PECTORIS; ARTICLE; BLOOD VISCOSITY; BODY MASS; BODY TEMPERATURE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; FEMALE; HEART VENTRICLE HYPERTROPHY; HEMATOCRIT; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; MENOPAUSE; MULTIVARIATE ANALYSIS; PREMATURE AGING; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK FACTOR; SMOKING; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; BLOOD; FLOW KINETICS; MIDDLE AGED; ONSET AGE;

ADULT; AGE OF ONSET; BLOOD VISCOSITY; CORONARY DISEASE; DIABETES MELLITUS; FEMALE; HUMANS; HYPERTENSION; MIDDLE AGED; REGRESSION ANALYSIS; RHEOLOGY; RISK FACTORS;

EID: 0036890297     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(02)00281-2     Document Type: Article

References (40)

1. Jan K.M., Chien S., Bigger J.T. Jr. Observations on blood viscosity changes after acute myocardial infarction. Circulation. 51:(6):1975;1079-1084.
2. Dodds A.J., Boyd M.J., Allen J., Bennett E.D., Flute P.T., Dormandy J.A. Changes in red cell deformability and other haemorrheological variables after myocardial infarction. Br. Heart J. 44:(5):1980;508-511.
3. Fuchs J., Weinberger I., Rotenberg Z., Erdberg A., Davidson E., Joshua H., et al. Plasma viscosity in ischemic heart disease. Am. Heart J., Part 1. 108:(3):1984;435-439.
4. Rainer C., Kawanishi D.T., Chandraratna P.A., Bauersachs R.M., Reid C.L., Rahimtoola S.H., et al. Changes in blood rheology in patients with stable angina pectoris as a result of coronary artery disease. Circulation. 76:(1):1987;15-20.
5. Lowe G.D., Fowkes F.G., Dawes J., Donnan P.T., Lennie S.E., Housley E. Blood viscosity, fibrinogen, and activation of coagulation and leukocytes in peripheral arterial disease and the normal population in the Edinburgh Artery Study. Circulation. 87:(6):1993;1915-1920.
6. de Simone G., Devereux R.B., Chien S., Alderman M.H., Atlas S.A., Laragh J.H. Relation of blood viscosity to demographic and physiologic variables and to cardiovascular risk factors in apparently normal adults. Circulation. 81:(1):1990;107-117.
7. de Simone G. Relationship between blood pressure and blood viscosity. Eur. Heart J. 14:(12):1993;1724-1725.
8. Rampling M.W. Haemorheological disturbances in hypertension: the influence of diabetes and smoking. Clin. Hemorheol. Microcirc. 21:(3-4):1999;183-187.
9. Lowe G.D., Wood D.A., Douglas J.T., Riemersma R.A., Macintyre C.C., Takase T., et al. Relationships of plasma viscosity, coagulation and fibrinolysis to coronary risk factors and angina. Thromb. Haemostasis. 65:(4):1991;339-343.
10. Chabanel A., Horellou M.H., Conard J., Samama M.M. Red blood cell aggregability in patients with a history of leg vein thrombosis: influence of post-thrombotic treatment. Br. J. Haematol. 88:(1):1994;174-179.
11. Sorlie P.D., Garcia-Palmieri M.R., Costas R. Jr., Havlik R.J. Hematocrit and risk of coronary heart disease: the Puerto Rico Health Program. Am. Heart J. 101:(4):1981;456-461.
12. Carter C., McGee D., Reed D., Yano K., Stemmermann G. Hematocrit and the risk of coronary heart disease: the Honolulu Heart Program. Am. Heart J. 105:(4):1983;674-679.
13. Dahlof B., Devereux R.B., Julius S., Kjeldsen S.E., Beevers G., de Faire U., et al. Characteristics of 9194 patients with left ventricular hypertrophy: the LIFE study. Losartan intervention for endpoint reduction in hypertension. Hypertension. 32:(6):1998;989-997.
14. Resch K.L., Ernst E., Matrai A., Buhl M., Schlosser P., Paulsen H.F. Can rheologic variables be of prognostic relevance in arteriosclerotic diseases? Angiology. 42:(12):1991;963-970.
15. Sweetnam P.M., Thomas H.F., Yarnell J.W., Beswick A.D., Baker I.A., Elwood P.C. Fibrinogen, viscosity and the 10-year incidence of ischaemic heart disease. Eur. Heart J. 17:(12):1996;1814-1820.
16. Lowe G., Rumley A., Norrie J., Ford I., Shepherd J., Cobbe S., et al. Blood rheology, cardiovascular risk factors, and cardiovascular disease: the West of Scotland Coronary Prevention Study. Thromb. Haemostasis. 84:(4):2000;553-558.
17. Bowdler A.J., Foster A.M. The effect of donor age on the flow properties of blood. I. Plasma and whole blood viscosity in adult males. Exp. Gerontol. 22:(3):1987;155-164.
18. Crawford J., Eye-Boland M.K., Cohen H.J. Clinical utility of erythrocyte sedimentation rate and plasma protein analysis in the elderly. Am. J. Med. 82:(2):1987;239-246.
19. Ernst E., Koenig W., Matrai A., Filipiak B., Stieber J. Blood rheology in healthy cigarette smokers: results from the MONICA project, Augsburg. Arteriosclerosis. 8:(4):1988;385-388.
20. Dintenfass L. Modifications of blood rheology during aging and age-related pathological conditions. Aging. 1:(2):1989;99-125.
21. Bonithon-Kopp C., Levenson J., Scarabin P.Y., Guillanneuf M.T., Kirzin J.M., Malmejac A., et al. Longitudinal associations between plasma viscosity and cardiovascular risk factors in a middle-aged French population. Atherosclerosis. 104:(1-2):1993;173-182.
22. Crowley J.P., Metzger J., Assaf A., Carleton R.C., Merrill E., Valeri C.R. Low density lipoprotein cholesterol and whole blood viscosity. Ann. Clin. Lab. Sci. 24:(6):1994;533-541.
23. Ernst E., Matrai A., Schmolzl C., Magyarosy I. Dose-effect relationship between smoking and blood rheology. Br. J. Haematol. 65:(4):1987;485-487.
24. Danesh J., Collins R., Appleby P., Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. J. Am. Med. Assoc. 279:(18):1998;1477-1482.
25. Lee A.J., Smith W.C., Lowe G.D., Tunstall-Pedoe H. Plasma fibrinogen and coronary risk factors: the Scottish Heart Health Study. J. Clin. Epidemiol. 43:(9):1990;913-919.
26. Koenig W., Sund M., Ernst E., Keil U., Rosenthal J., Hombach V. Association between plasma viscosity and blood pressure: results from the MONICA-project, Augsburg. Am. J. Hypertens. 4:(6):1991;529-536.
27. Smith W.C., Lowe G.D., Lee A.J., Tunstall-Pedoe H. Rheological determinants of blood pressure in a Scottish adult population. J. Hypertens. 10:(5):1992;467-472.
28. Kannel W.B. Hypertension, hypertrophy, and the occurrence of cardiovascular disease. Am. J. Med. Sci. 302:(4):1991;199-204.
29. Zannad F., Voisin P., Brunotte F., Bruntz J.F., Stoltz J.F., Gilgenkrantz J.M. Haemorheological abnormalities in arterial hypertension and their relation to cardiac hypertrophy. J. Hypertens. 6:(4):1988;293-297.
30. Anderson K.M., Wilson P.W., Odell P.M., Kannel W.B. An updated coronary risk profile: a statement for health professionals. Circulation. 83:(1):1991;356-362.
31. Levy D., Labib S.B., Anderson K.M., Christiansen J.C., Kannel W.B., Castelli W.P. Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy. Circulation. 81:(3):1990;815-820.
32. Barnes A.J., Locke P., Scudder P.R., Dormandy T.L., Dormandy J.A., Slack J. Is hyperviscosity a treatable component of diabetic microcirculatory disease? Lancet. 2:(8042):1977;789-791.
33. Paisey R.B., Harkness J., Hartog M., Chadwick T. The effect of improvement in diabetic control on plasma and whole blood viscosity. Diabetologia. 19:(4):1980;345-349.
34. Oughton J., Barnes A.J., Kohner E.M. Diabetes mellitus: its effect on the flow properties of blood. Horm. Metab. Res. Suppl. 11:1981;112-120.
35. Avellone G., Di Garbo V., Cordova R., Raneli G., De Simone R., Bompiani G. Coagulation, fibrinolysis and haemorheology in premenopausal obese women with different body fat distribution. Thromb. Res. 75:(3):1994;223-231.
36. Yarnell J.W., Sweetnam P.M., Rumley A., Lowe G.D. Lifestyle and hemostatic risk factors for ischemic heart disease: the Caerphilly Study. Arterioscler. Thromb. Vasc. Biol. 20:(1):2000;271-279.
37. Frohlich M., Schunkert H., Hense H.W., Tropitzsch A., Hendricks P., Doring A., et al. Effects of hormone replacement therapies on fibrinogen and plasma viscosity in postmenopausal women. Br. J. Haematol. 100:(3):1998;577-581.
38. Rosenson R.S., Tangney C.C., Mosca L.J. Hormone replacement therapy improves cardiovascular risk by lowering plasma viscosity in postmenopausal women. Arterioscler. Thromb. Vasc. Biol. 18:(12):1998;1902-1905.
39. Konukoglu D., Serin O., Ercan M. The relationship between plasma viscosity and cholesterol in postmenopausal women on hormone replacement therapy. Clin. Hemorheol. Microcirc. 22:(3):2000;223-228.
40. Danesh J., Collins R., Peto R., Lowe G.D. Haematocrit, viscosity, erythrocyte sedimentation rate: meta-analyses of prospective studies of coronary heart disease. Eur. Heart J. 21:(7):2000;515-520.